Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium
January 11, 2024 08:01 ET
|
Mainz BioMed NV
Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium
Mainz Biomed Provides Year-End Corporate Review 2023
January 09, 2024 08:01 ET
|
Mainz BioMed NV
Mainz Biomed Provides Year-End Corporate Review 2023
Mainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employees
December 19, 2023 08:01 ET
|
Mainz BioMed NV
Mainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employees
Mainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in Poland
December 12, 2023 08:01 ET
|
Mainz BioMed NV
Mainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in Poland
Mainz Biomed Reports Positive Topline Results from U.S. eAArly DETECT Study Evaluating Novel mRNA Biomarkers
December 05, 2023 09:01 ET
|
Mainz BioMed NV
Mainz Biomed Reports Positive Topline Results from U.S. eAArly DETECT Study Evaluating Novel mRNA Biomarkers
Mainz Biomed’s Presentation at the 35th Annual Piper Sandler Healthcare Conference to be Made Available via Webcast
November 29, 2023 08:01 ET
|
Mainz BioMed NV
Mainz Biomed’s Presentation at the 35th Annual Piper Sandler Healthcare Conference to be Made Available via Webcast
Mainz Biomed to Present at the 35th Annual Piper Sandler Healthcare Conference
November 20, 2023 08:01 ET
|
Mainz BioMed NV
Mainz Biomed to Present at the 35th Annual Piper Sandler Healthcare Conference
Mainz Biomed Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 16, 2023 08:01 ET
|
Mainz BioMed NV
Mainz Biomed Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Mainz Biomed Announces Closing of $5.0 million Registered Direct Offering
November 15, 2023 09:01 ET
|
Mainz BioMed NV
Mainz Biomed Announces Closing of $5.0 million Registered Direct Offering
Mainz Biomed Announces Pricing of $5.0 million Registered Direct Offering
November 13, 2023 09:00 ET
|
Mainz BioMed NV
Mainz Biomed Announces Pricing of $5.0 million Registered Direct Offering